论文部分内容阅读
目的分析2型糖尿病患者应用甘精胰岛素联合瑞格列奈药物治疗的路径及效果。方法选取我院2014年6月~2015年8月收治的84例2型糖尿病患者作为临床治疗对象，采取随机数字分组法将84例患者均分为观察组与对照组两组。对照组42例患者给予诺和灵30R胰岛素治疗方案，观察组42例患者给予甘精胰岛素联合瑞格列奈药物治疗方案，对比两组患者血糖指标改善情况差异。结果两组患者经不同药物方案治疗干预后，血糖水平相比干预前均得到了有效控制改善，但观察组42例患者各项血糖指标改善效果明显优于对照组患者，血糖控制达标率显著高于对照组患者，组间差异对比，<0.05，具有统计学意义。结论针对2型糖尿病患者定向给予甘精胰岛素联合瑞格列奈药物治疗方案，可有效控制改善患者血糖水平，提高患者预后生活质量。“,”Objective To analyze patients with type 2 diabetes using insulin Craig column joint is the path and the effect of drug treatment. Methods Select our June 2014 to August 2015 84 cases admitted during in patients with type 2 diabetes as object, take random digit grouping method 84 patients were divided into observation group. The control group of 42 patients treated with insulin therapy Novolin 30R , 42 patients in observation group were given insulin glargine combined with repaglinide in drug treatment . Results Two groups of patients with different drug solution treatment after the intervention,42 cases with the indicators improved effect control group patients, <0.05, with statistical significance. Conclusion Giving conclusion for patients with type 2 diabetes insulin associated repaglinide drug treatment.